Fresh science and technology news from Asia and the Pacific

Provided by AGP

Got News to Share?

Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on May 17, 2026

SpecterAI and CCLab Forge Partnership for Cybersecurity Certification and Post-Quantum Compliance in Vietnam & APAC
Australia’s Mandatory Climate Reporting Has Begun and Assurance Requirements Are Catching Many Organisations Short
Malaysia’s Largest Listed Companies Enter First NSRF Reporting Cycle as Readiness Gaps Emerge
Renewable Energy Capacity Is Expanding Faster Than Grids Can Coordinate It
NERC’s Rare Level 3 Alert Highlights Growing Operational Strain on the US Grid
CCR Enhances AI and Climate Risk Capabilities Across Its Technology Suite as Global Disclosure Demands Increase
Energy Networks Are Entering a US$900 Billion Infrastructure Era. Operational Intelligence Will Be Critical
UAE ESG Disclosure Requirements Are Driving a Shift Toward Formal Sustainability Reporting Across the Gulf
India’s Carbon Market Is Creating New Compliance and MRV Demands for Industry
US Companies Are Moving Beyond Annual ESG Reporting Toward Continuous Climate Data Management
CADChum Launches High-Speed CAD-to-3D Conversion for Real-Time Workflows
Why Disposable and Temporary Emails Are Becoming a Challenge for Online Platforms
Crypto News Today: AlphaPepe Presale Raises $1.25M While Solana Price Prediction Targets $450
Life360 Board of Directors Authorizes Up to $225 Million Multi-Year Share Repurchase Program to Offset Stock-Based Compensation Dilution
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
LiveRamp Announces Fourth Quarter and Fiscal Year 2026 Results
HeroHire Launches Autonomous AI Recruiter to Fix Hiring for the 99%
ApexQuant Announces Launch of Trading Technology Company Focused on Institutional-Style Trading Software for Private Market Participants
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
NANOBIOTIX ANNONCE LA PRÉSENTATION DE DONNÉES DE LA PREMIÉRE PARTIE DE L’ÉTUDE CLINIQUE RANDOMISÉE DE PHASE 2 EVALUANT JNJ-1900 (NBTXR3) DANS LES CANCERS DU POUMON DE STADE 3 INOPÉRABLE

Share us

on your social networks:

Sign up for:

Tech Focus Asia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.